SCHEMBL6495298

SCHEMBL6495298

O=C1CCC(c2ccc(C(=O)Cl)cc2)=NN1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ KCNH2 Q12809 1/20 0.52
▸ LMNA P02545 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ NPY1R P25929 1/20 0.50
▸ NPY2R P49146 1/20 0.50
▸ PDE3B Q13370 13/20 0.49
▸ PDE3A Q14432 12/20 0.49
▸ PDE4A P27815 4/20 0.49
▸ PDE4B Q07343 4/20 0.49
▸ PDE4C Q08493 4/20 0.49
▸ PDE4D Q08499 4/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503803 0.85 SMN1; SMN2 (0.67) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL10353452 0.84 SMN1; SMN2 (0.81) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL2846257 0.80 SMN1; SMN2 (0.68) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL8302890 0.80 SMN1; SMN2 (0.68) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL927560 0.78 SMN1; SMN2 (0.70) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL9687996 0.78 SMN1; SMN2 (0.70) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL8481664 0.77 LMNA (0.56) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL10556720 0.76 SMN1; SMN2 (0.68) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL6331085 0.76 SMN1; SMN2 (0.68) SMN1; SMN2KCNH2LMNAMAPTNPY1R
SCHEMBL7273533 0.76 SMN1; SMN2 (0.68) SMN1; SMN2KCNH2LMNAMAPTNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 — — US disclosed
US-6867206-B1 6-carboxyphenyldihydropyridazinone derivatives and use thereof BAYER AKTIENGESELLSCHAFT (DE) 2005-03-15 — — US disclosed
EP-1196392-A1 6-CARBOXYPHENYLDIHYDROPYRIDAZINONE DERIVATIVES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2002-04-17 — — EP disclosed
WO-2001000589-A1 6-CARBOXYPHENYLDIHYDROPYRIDAZINONE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2001-01-04 — — WO disclosed
Send feedback